Kurokawa, Yukinori
Matsuyama, Jin
Nishikawa, Kazuhiro
Takeno, Atsushi
Kimura, Yutaka
Fujitani, Kazumasa
Kawabata, Ryohei
Makari, Yoichi
Terazawa, Tetsuji
Kawakami, Hisato
Sakai, Daisuke
Shimokawa, Toshio
Satoh, Taroh
Funding for this research was provided by:
Osaka Clinical Study Supporting Organization
Article History
Received: 16 June 2020
Accepted: 1 August 2020
First Online: 10 August 2020
Compliance with ethical standards
:
: Yukinori Kurokawa has received personal fees from Taiho Pharmaceutical, Yakult Honsha, Ono Pharmaceutical, MSD, Daiichi Sankyo, Takeda Pharmaceutical, and Kaken Pharmaceutical and research funding from Taiho Pharmaceutical, Ono Pharmaceutical, and MSD. Kazuhiro Nishikawa has received personal fees from Bristol-Myers Squibb, Chugai Pharmaceutical, EA Pharma, Eli Lilly, Ono Pharmaceutical, Taiho Pharmaceutical, and Yakult Honsha. Hisato Kawakami has received personal fees from Bristol-Myers Squibb, Eli Lilly, MSD, Ono Pharmaceutical, Daiichi Sankyo, Taiho Pharmaceutical, AstraZeneca, Bayer, Chugai Pharmaceutical, and Takeda Pharmaceutical and research funding from Chugai Pharmaceutical, Taiho Pharmaceutical, and Eisai. Daisuke Sakai has received personal fees from Chugai Pharmaceutical and Daiichi Sankyo and research funding from Yakult Honsha, Chugai Pharmaceutical, Ono Pharmaceutical, Eli Lilly, Daiichi Sankyo, Astellas, and Incyte. Taroh Satoh has received personal fees from Taiho Pharmaceutical, Ono Pharmaceutical, Chugai Pharmaceutical, Yakult Honsha, Eli Lilly, MSD, Bristol-Myers Squibb, Astellas, Takara-Bio, and Sanofi-Aventis and research funding from Taiho Pharmaceutical, Ono Pharmaceutical, Chugai Pharmaceutical, Yakult Honsha, Eli Lilly, MSD, Bristol-Myers Squibb, Astellas, Giliad Sciences, Daiichi Sankyo, and Parexell and belongs to endowed department by Ono Pharmaceutical, Chugai Pharmaceutical, and Yakult Honsha. All remaining authors have declared no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments. This study was approved by the institutional review boards of all participating hospitals.
: Written informed consent was provided by all patients before enrollment.
Free to read: This content has been made available to all.